130 related articles for article (PubMed ID: 27822597)
1. Melanoma brain metastases: correlation of imaging features with genomic markers and patient survival.
Bordia R; Zhong H; Lee J; Weiss S; Han SW; Osman I; Jain R
J Neurooncol; 2017 Jan; 131(2):341-348. PubMed ID: 27822597
[TBL] [Abstract][Full Text] [Related]
2. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content.
Isiklar I; Leeds NE; Fuller GN; Kumar AJ
AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting.
Gibney GT; Gauthier G; Ayas C; Galebach P; Wu EQ; Abhyankar S; Reyes C; Guérin A; Yim YM
Cancer Med; 2015 Aug; 4(8):1205-13. PubMed ID: 25991583
[TBL] [Abstract][Full Text] [Related]
4. Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).
Sperduto PW; Jiang W; Brown PD; Braunstein S; Sneed P; Wattson DA; Shih HA; Bangdiwala A; Shanley R; Lockney NA; Beal K; Lou E; Amatruda T; Sperduto WA; Kirkpatrick JP; Yeh N; Gaspar LE; Molitoris JK; Masucci L; Roberge D; Yu J; Chiang V; Mehta M
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):812-816. PubMed ID: 29063850
[TBL] [Abstract][Full Text] [Related]
5. Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases.
Wolf A; Zia S; Verma R; Pavlick A; Wilson M; Golfinos JG; Silverman JS; Kondziolka D
J Neurooncol; 2016 May; 127(3):607-15. PubMed ID: 26852222
[TBL] [Abstract][Full Text] [Related]
6. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment.
Ly D; Bagshaw HP; Anker CJ; Tward JD; Grossmann KF; Jensen RL; Shrieve DC
J Neurosurg; 2015 Aug; 123(2):395-401. PubMed ID: 25768829
[TBL] [Abstract][Full Text] [Related]
7. Improved detection of metastatic melanoma by T2*-weighted imaging.
Gaviani P; Mullins ME; Braga TA; Hedley-Whyte ET; Halpern EF; Schaefer PS; Henson JW
AJNR Am J Neuroradiol; 2006 Mar; 27(3):605-8. PubMed ID: 16552002
[TBL] [Abstract][Full Text] [Related]
8. Correlation of MRI signal characteristics of intracranial melanoma metastases with BRAF mutation status.
Lasocki A; McArthur GA
Melanoma Res; 2022 Oct; 32(5):373-378. PubMed ID: 35979667
[TBL] [Abstract][Full Text] [Related]
9. Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.
Franceschi AM; Moschos SJ; Anders CK; Glaubiger S; Collichio FA; Lee CB; Castillo M; Lee YZ
J Comput Assist Tomogr; 2016; 40(5):803-5. PubMed ID: 27636126
[TBL] [Abstract][Full Text] [Related]
10. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging and quality-of-life outcomes in patients with brain metastasis and peritumoral edema who undergo Gamma Knife surgery.
Pan HC; Sun MH; Chen CC; Chen CJ; Lee CH; Sheehan J
J Neurosurg; 2008 Dec; 109 Suppl():90-8. PubMed ID: 19123894
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
Long GV; Menzies AM; Nagrial AM; Haydu LE; Hamilton AL; Mann GJ; Hughes TM; Thompson JF; Scolyer RA; Kefford RF
J Clin Oncol; 2011 Apr; 29(10):1239-46. PubMed ID: 21343559
[TBL] [Abstract][Full Text] [Related]
13. Virtual biopsy using MRI radiomics for prediction of BRAF status in melanoma brain metastasis.
Shofty B; Artzi M; Shtrozberg S; Fanizzi C; DiMeco F; Haim O; Peleg Hason S; Ram Z; Bashat DB; Grossman R
Sci Rep; 2020 Apr; 10(1):6623. PubMed ID: 32313236
[TBL] [Abstract][Full Text] [Related]
14. Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.
Dummer R; Goldinger SM; Turtschi CP; Eggmann NB; Michielin O; Mitchell L; Veronese L; Hilfiker PR; Felderer L; Rinderknecht JD
Eur J Cancer; 2014 Feb; 50(3):611-21. PubMed ID: 24295639
[TBL] [Abstract][Full Text] [Related]
15. Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases.
Meißner AK; Gutsche R; Galldiks N; Kocher M; Jünger ST; Eich ML; Montesinos-Rongen M; Brunn A; Deckert M; Wendl C; Dietmaier W; Goldbrunner R; Ruge MI; Mauch C; Schmidt NO; Proescholdt M; Grau S; Lohmann P
Neuro Oncol; 2022 Aug; 24(8):1331-1340. PubMed ID: 34935978
[TBL] [Abstract][Full Text] [Related]
16. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of different MRI sequences in the early detection of melanoma brain metastases.
Deike-Hofmann K; Thünemann D; Breckwoldt MO; Schwarz D; Radbruch A; Enk A; Bendszus M; Hassel J; Schlemmer HP; Bäumer P
PLoS One; 2018; 13(3):e0193946. PubMed ID: 29596475
[TBL] [Abstract][Full Text] [Related]
18. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
19. Visceral metastases from melanoma: findings on MR imaging.
Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
[TBL] [Abstract][Full Text] [Related]
20. Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases.
Gummadi T; Zhang BY; Valpione S; Kim C; Kottschade LA; Mittapalli RK; Chiarion-Sileni V; Pigozzo J; Elmquist WF; Dudek AZ
Melanoma Res; 2015 Feb; 25(1):75-9. PubMed ID: 25426645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]